TITLE:
An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)

CONDITION:
Bronchiolitis

INTERVENTION:
montelukast sodium

SUMMARY:

      The purpose of this study is to look at whether an investigational drug can treat the
      breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 3 Months to 24 Months
Criteria:

        Inclusion Criteria:

          -  Hospitalized or in an urgent/emergent-care setting at least 24 hours for a first or
             second episode of RSV-induced bronchiolitis. Approximately twenty percent of patients
             will be allowed in the study with a stay of less than 24 hours but need to meet a
             minimum predefined Respiratory Severity Score as required by the study.

        Exclusion Criteria:

          -  Asthma or other wheezing disorder. The Primary Investigator will evaluate whether
             there are other reasons why a child may not participate.
      
